Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Published Date: 01 Jul 2026

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

2.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

3.

A new therapeutic approach could help tackle radiation resistance in childhood brain tumors

4.

The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.

5.

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot